152 related articles for article (PubMed ID: 1909635)
21. Immunoassay for urinary pyridinoline: the new marker of bone resorption.
Seyedin SM; Kung VT; Daniloff YN; Hesley RP; Gomez B; Nielsen LA; Rosen HN; Zuk RF
J Bone Miner Res; 1993 May; 8(5):635-41. PubMed ID: 8511991
[TBL] [Abstract][Full Text] [Related]
22. Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview.
Simsek B; Karacaer O; Karaca I
Chin Med J (Engl); 2004 Feb; 117(2):291-5. PubMed ID: 14975218
[TBL] [Abstract][Full Text] [Related]
23. The urinary excretion of the collagen degradation markers pyridinoline and deoxypyridinoline in an experimental rat model of alcoholic bone disease.
Preedy VR; Sherwood RA; Akpoguma CI; Black D
Alcohol Alcohol; 1991; 26(2):191-8. PubMed ID: 1878079
[TBL] [Abstract][Full Text] [Related]
24. The urinary excretion of inorganic pyrophosphate in hyperparathyroidism, hyperthyroidism, Paget's disease and other disorders of bone metabolism.
Russell RG; Hodgkinson A
Clin Sci; 1969 Jun; 36(3):435-43. PubMed ID: 4307562
[No Abstract] [Full Text] [Related]
25. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM
Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
[TBL] [Abstract][Full Text] [Related]
26. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
[TBL] [Abstract][Full Text] [Related]
27. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
[TBL] [Abstract][Full Text] [Related]
28. [Chromatographic analysis of urinary amino acids in Paget's disease. II : clinical study].
Roques CF; Mazières B; Amigues H; Fournie A; Arlet J; Ruffié R
Rev Rhum Mal Osteoartic; 1976 Apr; 43(4):255-8. PubMed ID: 1273475
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of free plasma hydroxyproline measurement in metabolic bone disease.
Minisola S; Antonelli R; Mazzuoli G
J Clin Chem Clin Biochem; 1985 Sep; 23(9):515-9. PubMed ID: 4067520
[TBL] [Abstract][Full Text] [Related]
30. Urinary polypeptides related to collagen synthesis.
Krane SM; Muñoz AJ; Harris ED
J Clin Invest; 1970 Apr; 49(4):716-29. PubMed ID: 4315304
[TBL] [Abstract][Full Text] [Related]
31. Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.
Torres R; de la Piedra C; Rapado A
Calcif Tissue Int; 1991 Jul; 49(1):14-6. PubMed ID: 1893290
[TBL] [Abstract][Full Text] [Related]
32. Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone.
Bower L; Manley G
J Clin Pathol; 1981 Oct; 34(10):1097-101. PubMed ID: 7309892
[TBL] [Abstract][Full Text] [Related]
33. Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction.
Brazier M; Kamel S; Maamer M; Agbomson F; Elesper I; Garabedian M; Desmet G; Sebert JL
J Bone Miner Res; 1995 Nov; 10(11):1753-61. PubMed ID: 8592953
[TBL] [Abstract][Full Text] [Related]
34. Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis.
Nur E; Mairuhu W; Biemond BJ; van Zanten AP; Schnog JJ; Brandjes DP; Otten HM;
Am J Hematol; 2010 Nov; 85(11):902-4. PubMed ID: 20882525
[TBL] [Abstract][Full Text] [Related]
35. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
Randall AG; Kent GN; Garcia-Webb P; Bhagat CI; Pearce DJ; Gutteridge DH; Prince RL; Stewart G; Stuckey B; Will RK; Retallack RW; Price RI; Ward L
J Bone Miner Res; 1996 Aug; 11(8):1176-84. PubMed ID: 8854254
[TBL] [Abstract][Full Text] [Related]
36. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis.
Delmas PD; Schlemmer A; Gineyts E; Riis B; Christiansen C
J Bone Miner Res; 1991 Jun; 6(6):639-44. PubMed ID: 1887826
[TBL] [Abstract][Full Text] [Related]
37. Nondialyzable urinary hydroxyproline as an index of bone collagen formation.
Haddad JG; Couranz S; Avioli LV
J Clin Endocrinol Metab; 1970 Mar; 30(3):282-7. PubMed ID: 4983851
[No Abstract] [Full Text] [Related]
38. Monoclonal antibody assay for free urinary pyridinium cross-links.
Gomez B; Ardakani S; Evans BJ; Merrell LD; Jenkins DK; Kung VT
Clin Chem; 1996 Aug; 42(8 Pt 1):1168-75. PubMed ID: 8697572
[TBL] [Abstract][Full Text] [Related]
39. Galactosyl hydroxylysine in assessment of Paget's bone disease.
Michalsky M; Stepan JJ; Wilczek H; Formankova J; Moro L
Clin Chim Acta; 1995 Jan; 234(1-2):101-8. PubMed ID: 7758208
[TBL] [Abstract][Full Text] [Related]
40. [Assay of urinary pyridinoline and deoxypyridinoline as potential markers of the rate of bone resorption: usefulness of urinary pyridinoline and deoxypyridinoline in patients with prostate cancer with bone metastases].
Takeuchi S; Yoshida K
Nihon Hinyokika Gakkai Zasshi; 1994 Oct; 85(10):1521-7. PubMed ID: 7990300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
